We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Study design, rationale, and baseline characteristics: evaluation of fenofibric acid on carotid intima-media thickness in patients with type IIb dyslipidemia with residual risk in addition to atorvastatin therapy (FIRST) trial.
- Authors
Davidson, Michael; Rosenson, Robert S; Maki, Kevin C; Nicholls, Stephen J; Ballantyne, Christie M; Setze, Carolyn; Carlson, Dawn M; Stolzenbach, James
- Abstract
Elevated triglycerides (TG) and low high-density lipoprotein cholesterol (HDL-C) levels contribute to cardiovascular disease risk and can be effectively treated with fenofibric acid. A trial is under way to evaluate the effect of once-daily fenofibric acid or placebo on carotid intima-media thickness (CIMT) progression in patients with controlled low-density lipoprotein cholesterol (LDL-C) levels achieved through atorvastatin treatment, but with high TG and low HDL-C levels.
- Publication
Cardiovascular drugs and therapy, 2012, Vol 26, Issue 4, p349
- ISSN
1573-7241
- Publication type
Journal Article
- DOI
10.1007/s10557-012-6395-z